Vertex Reports First Quarter 2024 Financial Results
06 May 2024 //
BUSINESSWIRE
Vertex announces advancements of pain signal inhibitor, suzetrigine
20 Apr 2024 //
PHARMABIZ
Vertex Updates On Suzetrigine For Acute And Neuropathic Pain
18 Apr 2024 //
BUSINESSWIRE